Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care
2 other identifiers
observational
50
1 country
1
Brief Summary
Observational protocol to analyse routine vancomycin serum levels of patients under intensive care and to obtain percentage of patients that achieve therapeutic values.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 24, 2011
CompletedFirst Posted
Study publicly available on registry
February 25, 2011
CompletedMarch 23, 2012
March 1, 2012
February 24, 2011
March 21, 2012
Conditions
Eligibility Criteria
Pediatric oncology patients on intensive care unit for treatment of infections.
You may qualify if:
- Hospitalized pediatric oncology patients
- Patients under vancomycin treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Grupo de Apoio ao Adolescente e à Criança com Câncer
São Paulo, São Paulo, 04023-062, Brazil
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 24, 2011
First Posted
February 25, 2011
Study Start
January 1, 2011
Last Updated
March 23, 2012
Record last verified: 2012-03